Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002122411-26-000001
Filing Date
2026-08-07
Accepted
2026-08-07 11:40:39
Documents
1
Period of Report
2026-08-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3633
  Complete submission text file 0002122411-26-000001.txt   5391
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Issuer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA
Business Address
Sharma Mani (Reporting) CIK: 0002122411 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11960 | Film No.: 261252573